CIGNA Laboratory Testing Services Policy Update: What Billing Teams Need to Know (2026)

CIGNA has issued a modification to its Laboratory Testing Services coverage policy, effective March 14, 2026. This update affects how Cigna evaluates medical necessity for a broad range of diagnostic lab services, and billing teams that don't review the changes before claims go out risk increased denials, prior authorization gaps, and potential recoupments. If your practice orders or bills laboratory services for Cigna members, this policy deserves immediate attention.

What Changed in CIGNA's Laboratory Testing Services Policy (0604)

Cigna, officially known as The Cigna Group, periodically revises its coverage position criteria for laboratory testing to reflect updates in clinical evidence, changes to CPT code sets, and evolving standards of medical practice. Policy 0604 — Laboratory Testing Services — is one of Cigna's broader-scope lab policies, covering the medical necessity framework that governs when diagnostic testing is considered covered, not covered, or experimental/investigational.

The March 14, 2026 modification signals that Cigna has updated its internal clinical criteria, coverage language, or both. While the specific line-by-line changes are available through the full policy document and version diff tools, modifications to a policy of this scope can affect everything from routine chemistry panels to more specialized molecular and genetic testing — depending on what clinical indications Cigna has added, removed, or requalified.

For revenue cycle teams, "modified" doesn't always mean minor. A single change to a covered indication or a shift in how Cigna defines medical necessity for a test category can cascade across hundreds of claims per month in a high-volume lab or multi-specialty group practice.

CIGNA Laboratory Testing Coverage: How the Policy Framework Works

Cigna's laboratory testing coverage decisions generally hinge on a few core determinations: whether a test is considered medically necessary for a given diagnosis, whether it is considered experimental or investigational, and whether it meets the specific clinical criteria outlined in the policy at the time of service.

Under most Cigna policies in this category, a laboratory test is covered when it is:

• Ordered by a licensed clinician to diagnose, treat, or monitor a covered condition
• Supported by documented clinical indications in the medical record
• Consistent with widely accepted clinical guidelines or Cigna's internal evidence review

Tests that fall outside those criteria — including those ordered for screening purposes without a qualifying diagnosis, tests deemed to have insufficient clinical evidence, or tests duplicating information already available — are typically denied as not medically necessary or classified as experimental/investigational.

This framework matters because Cigna's 0604 policy applies across a wide range of test types. A modification could affect how a specific test category is classified or how tightly Cigna expects documentation of clinical indication to match the coverage criteria.

Affected Codes

The published policy data for this update does not list specific CPT, HCPCS, or ICD-10-CM codes. Cigna's Laboratory Testing Services policy (0604) is a broad coverage framework policy, and applicable codes are typically identified within the full policy document and its associated billing and coding guidelines.

Billing teams should access the full policy at app.payerpolicy.org/p/cigna/mm_0604_coveragepositioncriteria_labtesting. and cross-reference any lab CPT codes your practice regularly bills against Cigna's updated criteria. Pay particular attention to:

• Molecular pathology codes (Tier 1 and Tier 2)
• Genomic sequencing procedure codes
• Multianalyte assays with algorithmic analysis (MAAA) codes
• Routine chemistry and hematology panels
• Microbiology and infectious disease testing codes

Until you can pull the full code list from the policy document, do not assume previously covered codes remain unchanged under the March 2026 revision.

Prior Authorization and Documentation Requirements for CIGNA Lab Claims

Whether a specific lab test requires prior authorization under Cigna depends on the test category, the plan type (commercial, Medicare Advantage, or managed Medicaid), and the specific CPT code being billed. Cigna's prior authorization requirements for laboratory services are maintained separately from the coverage criteria in policy 0604, but both must align for a claim to pay.

What the 0604 policy modification most directly affects is the medical necessity standard — meaning even if a test doesn't require prior auth, it can still be denied on post-payment review if documentation in the patient record doesn't support the updated criteria.

Best practice: treat every lab order as a documentation exercise. The clinical indication in the order, the diagnosis code on the claim, and the note in the chart should all tell the same story — one that maps directly to Cigna's stated coverage criteria.

What Your Billing Team Should Do